(Q36948557)

English

Randomized control trial for the assessment of the anti-albuminuric effects of topiroxostat in hyperuricemic patients with diabetic nephropathy (the ETUDE study).

scientific article published on May 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 August 2017

Randomized control trial for the assessment of the anti-albuminuric effects of topiroxostat in hyperuricemic patients with diabetic nephropathy (the ETUDE study). (English)

1 reference

Europe PubMed Central

17 August 2017

randomized controlled trial

1 reference

based on heuristic

inferred from title

diabetic nephropathy

1 reference

based on heuristic

inferred from title

author name string

Sawako Kato

1

1 reference

Europe PubMed Central

17 August 2017

Masahiko Ando

2

1 reference

Europe PubMed Central

17 August 2017

Toshihiro Mizukoshi

3

1 reference

Europe PubMed Central

17 August 2017

Takanobu Nagata

4

1 reference

Europe PubMed Central

17 August 2017

Takayuki Katsuno

5

1 reference

Europe PubMed Central

17 August 2017

Tomoki Kosugi

6

1 reference

Europe PubMed Central

17 August 2017

Naotake Tsuboi

7

1 reference

Europe PubMed Central

17 August 2017

Shoichi Maruyama

8

1 reference

Europe PubMed Central

17 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2016

1 reference

Europe PubMed Central

17 August 2017

Nagoya journal of medical science

1 reference

Europe PubMed Central

17 August 2017

78

1 reference

Europe PubMed Central

17 August 2017

2

1 reference

Europe PubMed Central

17 August 2017

135-142

1 reference

Europe PubMed Central

17 August 2017

Serum Uric Acid and Risk of CKD in Type 2 Diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Diabetic nephropathy: landmark clinical trials and tribulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Treatment of gout patients with impairment of renal function: a systematic literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Oxidative stress/angiotensinogen/renin-angiotensin system axis in patients with diabetic nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Uric acid and chronic kidney disease: which is chasing which?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Revised equations for estimated GFR from serum creatinine in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Serum uric acid: a risk factor and a target for treatment?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Febuxostat compared with allopurinol in patients with hyperuricemia and gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Predictors of diabetic end-stage renal disease in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Factors influencing long-term survival in patients on chronic dialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

29 September 2017

An overview of regular dialysis treatment in Japan (as of 31 December 2012).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

27 June 2018

Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

4 September 2018

Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

4 September 2018

Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

4 September 2018

Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4885813

4 September 2018

A new xanthine oxidase inhibitor: the uric acid reduction and additional efficacy in CKD patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27303100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical practice. Gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/27303100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36948557&oldid=1629749476"